Top Biotechnology companies in Denmark by Revenue

This ranking features the top 15 Biotechnology companies in Denmark ranked by Revenue, totalling a Revenue of USD 9.52 B, for January 15, 2025.
#
Name
Revenue
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 2.95 B
Dec. 31, 2023 USD 5.46 0.56%

Denmark

2
USD 2.65 B
Dec. 31, 2023 USD 54.16 -1.39%

Denmark

3
USD 2.44 B
Dec. 31, 2023 USD 216.88 1.28%

Denmark

4
USD 1.05 B
Dec. 31, 2023 USD 26.62 -0.36%

Denmark

5
USD 294.39 M
Dec. 31, 2023 USD 131.57 -1.84%

Denmark

6
USD 58.73 M
June 30, 2024 USD 70.50 0.61%

Denmark

7
USD 50.74 M
Dec. 31, 2023 USD 95.84 0.08%

Denmark

8
USD 30.34 M
Dec. 31, 2023 USD 91.43 -1.85%

Denmark

9
USD 4.58 M
Dec. 31, 2023 USD 0.20 -2.77%

Denmark

10
USD 1.82 M
Dec. 31, 2023 USD 0.63 -3.68%

Denmark

11
USD 1.66 M
Dec. 31, 2023 USD 0.57 1.47%

Denmark

12
USD 1.03 M
Dec. 31, 2023 USD 1.93 -6.19%

Denmark

13
USD 695.84 K
Dec. 31, 2023 USD 2.17 5.88%

Denmark

14
USD 62.61 K
Dec. 31, 2023 USD 3.98 0.01%

Denmark

15
USD 0.00
Dec. 31, 2023 USD 0.64 1.38%

Denmark

Frequently Asked Questions
  • Which Biotechnology company in Denmark has the highest Revenue ?

    The Biotechnology company in Denmark with the highest Revenue is H. Lundbeck A/S (Copenhagen Stock Exchange: HLUN-B.CO) at USD 2.95 B.

  • Which Biotechnology company in Denmark has the lowest Revenue ?

    The Biotechnology company in Denmark with the lowest Revenue is Initiator Pharma A/S (Stockholm Stock Exchange: INIT.ST) at USD 0.00.